CACNA2D1 and endometrial carcinoma: First, endogenous CACNA2D1 expression was examined by Western blotting in eight endometrial carcinoma cell lines, among which the HEC-108, KLE, Ishikawa and HEC-06 cell lines showed relatively higher levels of CACNA2D1 than the other four EC cell lines (Figure 5A).